31/5/17 || Speeches!
seen from Japan
seen from Canada
seen from United States

seen from United Kingdom

seen from United States

seen from United States
seen from United States

seen from Kazakhstan
seen from Poland
seen from Romania
seen from China
seen from China
seen from Japan

seen from United States
seen from France

seen from United States

seen from United States

seen from Hong Kong SAR China

seen from United States
seen from United States
31/5/17 || Speeches!
THE HOLLOW MEN
we are the hollow men/we are the stuffed men
deaths dream kingdom
between the (x)/and the (y)/ falls the shadow
this is the way the world ends/not with a bang but with a whimper
Workout Schedule and Modules for 2017
Module B:
No masters or kings When the ritual begins There is no sweeter innocence Than our gentle sin
T.S Eliot’s 1915 poem The Love Song of J. Alfred Prufrock is the detailed exploration and observation of the manner in which the self, cultivated by the titular nihilist, unravels when he experiences infatuation.
HEDIS
HEDIS is the Healthcare Effectiveness Data and Information Set and is a tool used by many insurance plans. The measures are created by NCQA (National Committee for Quality Assurance).
HEDIS measures address a broad range of important health issues. Some of these measures are.
Asthma Medication Use
Persistence of Beta-Blocker Treatment after a Heart Attack
Controlling High Blood Pressure
Comprehensive Diabetes Care
Breast Cancer Screening / Prostate Cancer Screening
Antidepressant Medication Management
Childhood and Adolescent Immunization Status
Childhood and Adult Weight/BMI Assessment
HEDIS measures tie into stars that Medicare assigns to health plans, so the company wants to make sure that members are getting all of the necessary screenings and appointments! This also greatly improves outcomes, so it is a priority for the plan.
I’ve learned a lot about HEDIS and Medicare Stars while I have been here and I have heard all of the great things that this health plan does for members!
Meet and Greets!
I’ve gotten to meet with crucial employees to the company and learn what they do! I’ve met with company vice presidents, doctors, case managers, nurses, the physician engagement team and pharmacists. I’ve even had lunch with the CEO (twice)!! I have loved getting the opportunity to ask each person what their typical day is like and hearing their role at the company.
My rotation site employs 15 pharmacists who each have very different jobs, and are all SO COOL!!!!!!!! There are so many opportunities here for pharmacists that I never knew about!!!
Here are a few of the positions
Medicare Pharmacist
Oversees medicare formulary, manages medicare clinical programs
Medicaid Pharmacist
Oversees medicaid formulary, manages medicaid clinical programs
Manger of Formulary and Clinical Operations
Oversees commercial formularies, heads P+T committee, manages medication exception requests
Manged Care Pharmacists
I can’t define this one, because they all do so much!! Some of the things they do is complete medical exception requests, help with appeals, talk to members, sit on various committees within the company and help manage the formularies
Clinical Pharmacy Specialist
Embedded in Enhanced Primary Care (EPC) practices, which are this company’s version of a Patient Centered Medical Home! Participate in MTM services and do training/information sessions for contracted MTM pharmacists.
Medicare Stars Pharmacist
Evaluates HEDIS (Healthcare Effectiveness Data and Information Set) measures and creates programs/outreach to make sure patients are getting optimal care and that HEDIS measures are met
Director of Pharmaceutical Care Programs
This is my preceptor and the best way I can summarize her job is... doing ABSOLUTELY EVERYTHING!!!!!!! She is everywhere and knows everything ever about every drug and condition! So maybe part of her job is being the most informed person on earth, I’m not sure :P She is so involved in every aspect of pharmacy here, and it is very cool to see what she does each day!!!!!!! She is so great at showing us strange cases, orphan drugs and training us to understand why the company does specific things!
Vice President, Clinical Integration/Chief Pharmacy Office
Another person who does EVERYTHING! She is a pharmacist with a business mind, so is a great negotiator and manager. She is in charge of quality and pharmacy and works very hard with everyone in the area/the PBM/pharma to ensure that the best care can go out to the members.
New Drugs!
While I’ve been on rotation, some pretty huge (and VERY EXPENSIVE) drugs have been approved by the FDA!
Entresto (sacubitril/valsartan)
Entresto is for treatment of heart failure with reduced ejection fraction. It is indicated in patients NYHA class II-IV, and is used to reduce the risk of cardiovascular death and heart failure hospitalizations. Sacubitril has a novel mechanism of action and is a neprilysin inhibitor. Entresto will be administered in conjunction with other heart failure therapies, in place of an ACE or other ARB. It has been proven to significantly reduce risk of cardiovascular death when compared to enalapril alone.
Cost: $12.50 a day, or about $4,500 a year
Praluent (alirocumab)
Praluent is the first of two PCSK9 inhibitors coming out this summer! It is a subcutaneous injection given every 2 weeks that has shown to reduce LDL 50 - 70%. Praluent is a monoclonal antibody that binds to PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 inhibitors decrease LDL receptors degradation by PCSK9, and thereby improve LDL-C clearance and lower plasma LDL-C. This medication has been approved for use in addition to diet and maximally tolerated statin therapy in adult patients with heterozygous familial hypercholesterolemia (HeFH) or patients with clinical atherosclerotic cardiovascular disease such as heart attacks or strokes, who require additional lowering of LDL cholesterol
Cost: $16,000 a year (to put this in perspective, with this insurance plan, you can get a year of typical ARBs for $40 - $100 a year)
Orkambi (lumacaftor/ivacaftor)
Orkambi is the first of its kind to treat the cause of the disease in cystic fibrosis who have two copies of a specific mutation. The F508del mutation, which causes the production of an abnormal protein that disrupts how water and chloride are transported in the body. Having two copies of this mutation (one inherited from each parent) is the leading cause of CF. This drug may be a breakthrough therapy option for patients with CF and must be given for life
Cost: $310,800.10 per year